Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 3/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.30 |
| ▸ | CDK4 | P11802 | 1/20 | 0.30 |
| ▸ | CCND1 | P24385 | 1/20 | 0.30 |
| ▸ | CDK7 | P50613 | 1/20 | 0.30 |
| ▸ | CDK9 | P50750 | 1/20 | 0.30 |
| ▸ | CCNH | P51946 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13337033 | 1.00 | SMYD3 (0.39) | SMYD3MDM2GAAL3MBTL1IRAK4 | |
| SCHEMBL17776579 | 1.00 | SMYD3 (0.39) | SMYD3MDM2GAAL3MBTL1IRAK4 | |
| SCHEMBL23333333 | 0.87 | SMYD3 (0.37) | SMYD3MDM2GAAL3MBTL1 | |
| SCHEMBL2600363 | 0.86 | MDM2 (0.41) | MDM2GAAL3MBTL1IRAK4DRD2 | |
| SCHEMBL16171239 | 0.86 | MDM2 (0.41) | MDM2GAAL3MBTL1IRAK4DRD2 | |
| SCHEMBL681668 | 0.86 | — | — | |
| SCHEMBL18458286 | 0.86 | MDM2 (0.41) | MDM2GAAL3MBTL1IRAK4DRD2 | |
| SCHEMBL17776569 | 0.85 | MDM2 (0.41) | SMYD3MDM2CCNT1CDK4CCND1 | |
| SCHEMBL2621567 | 0.85 | MDM2 (0.41) | SMYD3MDM2CCNT1CDK4CCND1 | |
| SCHEMBL17776568 | 0.85 | MDM2 (0.41) | SMYD3MDM2CCNT1CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3154937-B1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | FINA TECHNOLOGY (US) | 2024-05-22 | — | — | EP | claimed |
| US-10584823-B2 | Chlorine-resistant polyethylene compound and articles made therefrom | FINA TECHNOLOGY, INC. (US) | 2020-03-10 | — | — | US | claimed |
| EP-3154937-A1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | Fina Technology, Inc. (US) | 2017-04-19 | — | — | EP | claimed |
| US-20170089503-A1 | Chlorine-resistant Polyethylene Compound and Articles Made Therefrom | TOTAL AMERICAN SERVICES, INC. | 2017-03-30 | — | — | US | claimed |
| WO-2015191721-A1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | FINA TECHNOLOGY, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| US-4217237-A | Process for removing carbon dioxide containing acidic gases from gaseous mixtures using a basic salt activated with a hindered amine | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-08-12 | — | — | US | claimed |
| US-4112050-A | Process for removing carbon dioxide containing acidic gases from gaseous mixtures using a basic salt activated with a hindered amine | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-09-05 | — | — | US | claimed |
| US-20250161906-A1 | METHOD FOR REMOVING GASES | EVONIK OPERATIONS GMBH (DE) | 2025-05-22 | — | — | US | disclosed |
| EP-4556101-A1 | GAS REMOVAL METHOD | Evonik Operations GmbH (DE) | 2025-05-21 | — | — | EP | disclosed |
| CN-120019859-A | Method for removing gas | 赢创运营有限公司 | 2025-05-20 | — | — | CN | disclosed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| EP-3154937-B1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | FINA TECHNOLOGY (US) | 2024-05-22 | — | — | EP | disclosed |
| US-20240018150-A1 | SMALL MOLECULAR INHIBITOR AGAINST BTK AND/OR BTK C481S AND USE THEREOF | ARROMAX PHARMATECH CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| US-8575203-B2 | Chemical compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-11-05 | — | — | US | disclosed |
| US-8575203-B2 | Chemical compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-11-05 | — | — | US | disclosed |
| US-20120094976-A1 | NEW CHEMICAL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-04-19 | — | — | US | disclosed |
| WO-2012026452-A1 | TRIAZINE RING-CONTAINING POLYMER AND MEMBRANE-FORMING COMPOSITION CONTAINING THE SAME | 日産化学工業株式会社 (JP) | 2012-03-01 | — | — | WO | disclosed |
| WO-2007125405-A2 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| US-4112050-A | Process for removing carbon dioxide containing acidic gases from gaseous mixtures using a basic salt activated with a hindered amine | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-09-05 | — | — | US | disclosed |
| US-4094957-A | CARBON DIOXIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094976-A1 | NEW CHEMICAL COMPOUNDS | CCNB1, MKI67, CCNA1 | SMYD3 2233/4885MDM2 1399/4885GAA 338/4885 |
| US-20240018150-A1 | SMALL MOLECULAR INHIBITOR AGAINST BTK AND/OR BTK C481S AND USE THEREOF | BTK, SYK, LCK | SMYD3 2479/4885MDM2 1572/4885GAA 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.